Oncternal And SpringWorks Among Early ASCO Winners And Losers

SpringWorks Declines Despite Positive Results

 
• By Andrew McConaghie
  
Nasdaq
Many NASDAQ-listed biotech companies are in need of a share price bounce, which are hard to come by in the current market. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category